H ypertension is a highly prevalent condition and, when untreated, has myriad devastating consequences including myocardial infarction, cardiomyopathy, renal failure, and stroke.
Extensive clinical data support the treatment of hypertension and demonstrates the reduction in cardiovascular events, stroke, and death in patients with hypertension whose blood pressure is controlled (1) .
Despite optimal medication management (concurrent use of 3 different medications of different classes, at maximally tolerated doses, 1 of which is a diuretic agent) and ruling out secondary causes of hypertension, up to 20% to 30% of patients with hypertension continue to have elevated blood pressure and are defined as having treatment-resistant hypertension.
These patients are at a 3-fold increased risk of adverse cardiovascular outcomes compared with those with treatment-responsive hypertension (2) . It is this subgroup of patients in whom additional therapies are needed to successfully control their hypertension and to reduce their risk of major adverse events. Only recently has the medical community begun to fully embrace that this population requires a special focus that goes beyond simple medical adherence, medica- Bisognano has received consulting fees from CVRx and Vascular Dynamics. Dr. Paivanas has reported that he has no relationships relevant to the contents of this paper to disclose. 
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Unilateral Carotid Body Resection in Resistant Hypertension
A U G U S T 2 0 1 6 : 3 2 5 -7 this demonstrates an interesting target for future nonpharmacological therapies. Whether these therapies are surgical excision, catheter-based ablation, or permanent device implantation remains to be seen, and it would be wonderful to see each of these procedures developed to yield efficacy for the wide variety of patients with this disease. Now that this technique is proven feasible, follow-up studies with larger numbers of patients will be needed to assess the efficacy and also hopefully determine which patients will respond significantly to the therapy. The authors' observation of elevated hypoxic ventilator response and respiratory frequency in responders suggest that this might be a fruitful tool for identifying patients who will be more likely to respond to the therapy before undergoing a procedure. Ideally, with additional research in this field, clinicians will have the tools to identify patients who are appropriate for a nonpharmacological intervention and will be able to select between multiple procedures to tailor appropriate interventions to a given patient before he or she undergoes a procedure.
Although controlling hypertension with a few easily tolerated and inexpensive medications benefits a large majority of patients, the continued high burden of myocardial infarction, heart failure, and stroke in patients with treatment-resistant hypertension shines a light on the need to continue to develop new treatments for this disease. Evolving invasive approaches to hypertension management, such as carotid body resection, offer an exciting potential to fill this need.
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